I t’s hard to argue that the introduction of drugs like Ozempic has been anything short of revolutionary for people looking ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

Amble Health's website states it is a platform connecting patients to licensed healthcare professionals online, who can ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

The Outsourcing Facilities Association filed two lawsuits against the FDA about the removal of Tirzepatide and Semaglutide from the drug shortage list, but judges allowed the FDA’s plan to ban the ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market ...

Ozempic was originally approved by the Food and Drug Administration (FDA) to treat people with Type 2 diabetes, who risk ...

Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...

The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs containing semaglutide, the active ingredient in Ozempic, Wegovy and Rybelsus ...